<p>随着 2025 年接近尾声，美国股市经历了一个强劲的年度，主要指数均实现了显著的涨幅，尽管最后略显疲软。在这种环境下，识别高内部持股的成长型公司尤为吸引人，因为内部人士的信心通常预示着长期成功的潜力以及与股东利益的一致性。</p>
<h3>美国高内部持股的十大成长型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>超微电脑 (SMCI)</td>
<td>13.9%</td>
<td>50.7%</td>
</tr>
<tr>
<td>StubHub Holdings (STUB)</td>
<td>14.1%</td>
<td>59%</td>
</tr>
<tr>
<td>SES AI (SES)</td>
<td>12%</td>
<td>68.9%</td>
</tr>
<tr>
<td>Prairie Operating (PROP)</td>
<td>31.8%</td>
<td>100%</td>
</tr>
<tr>
<td>Niu Technologies (NIU)</td>
<td>37.2%</td>
<td>93.7%</td>
</tr>
<tr>
<td>Credo Technology Group Holding (CRDO)</td>
<td>10.1%</td>
<td>30.7%</td>
</tr>
<tr>
<td>Corcept Therapeutics (CORT)</td>
<td>11.5%</td>
<td>43.3%</td>
</tr>
<tr>
<td>Bitdeer Technologies Group (BTDR)</td>
<td>33.4%</td>
<td>135.5%</td>
</tr>
<tr>
<td>Atour Lifestyle Holdings (ATAT)</td>
<td>18%</td>
<td>24.4%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.5%</td>
<td>29.0%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们高内部持股快速成长的美国公司筛选器中的 211 只股票的完整列表。</p>
<p>下面我们重点介绍几家我们独家的筛选器中的最爱。</p>
<h2>Abeona Therapeutics (ABEO)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Abeona Therapeutics Inc.是一家临床阶段的生物制药公司，专注于开发针对危及生命疾病的基因和细胞疗法，市值为 2.8071 亿美元。</p>
<p><strong>运营：</strong> Abeona Therapeutics Inc.目前没有报告任何收入细分，因为它专注于开发针对危及生命疾病的基因和细胞疗法。</p>
<p><strong>内部持股：</strong> 10.3%</p>
<p>Abeona Therapeutics 是一家拥有大量内部持股的公司，正经历显著的增长潜力。最近实现盈利，交易价格低于其估计的公允价值和同行。尽管过去一年股东稀释了一些股份，但 Abeona 的收入预计将以每年 42.5% 的速度增长，超过美国市场的平均水平。该公司最近的产品开发包括 FDA 批准的 ZEVASKYN 基因疗法，用于治疗罕见皮肤疾病，以及战略性领导任命，以增强业务运营和发展战略。</p>
<ul>
<li>点击这里深入了解 Abeona Therapeutics 的完整分析和未来增长报告。</li>
<li>我们的估值报告揭示了 Abeona Therapeutics 的股票可能在折扣交易。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/39d195f1-9226-485e-ab87-b8869e7f9946/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/39d195f1-9226-485e-ab87-b8869e7f9946/chart/earnings-and-revenue-growth"/></p>
<p>截至 2026 年 1 月的 ABEO 收益和收入增长</p>
<h2>Streamex (STEX)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Streamex Corp.是一家现实世界资产代币化公司，提供机构级基础设施，市值为 4.6152 亿美元。</p>
<p><strong>运营：</strong> 提供的文本中未指定 Streamex Corp.的收入细分。</p>
<p><strong>内部持股：</strong> 16.1%</p>
<p>Streamex 拥有显著的内部持股，通过创新举措如开放项目和战略合作伙伴关系，正处于增长的有利位置。该公司专注于代币化现实世界资产，例如其黄金支持的 GLDY 代币，与监管进展相一致，以增强市场透明度和效率。尽管在 2025 年第三季度遭遇了 1558 万美元的财务损失和股东稀释，Streamex 的收入预计将以每年超过 100% 的速度快速增长，超过美国市场的平均水平。</p>
<ul>
<li>点击这里访问我们的完整增长分析报告，以了解 Streamex 的动态。</li>
<li>根据我们的估值报告，Streamex 的股价可能偏高。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d17f23ca-2239-4854-a67b-12352d918c07/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d17f23ca-2239-4854-a67b-12352d918c07/chart/earnings-and-revenue-growth"/></p>
<p>截至 2026 年 1 月的 STEX 收益和收入增长</p>
<h2>Fiverr International (FVRR)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Fiverr International Ltd.运营一个全球在线市场，市值约为 7.2795 亿美元。</p>
<p><strong>运营：</strong> 该公司从其互联网软件和服务部门产生 4.2740 亿美元的收入。</p>
<p><strong>内部持股：</strong> 11.6%</p>
<p>Fiverr International 拥有大量内部持股，展现出强劲的收益增长，在 2025 年第三季度报告的净收入为 554 万美元，而去年为 135 万美元。尽管收入增长预测落后于更广泛的市场，年增长率为 6.3%，但其收益预计将以每年 47.5% 的速度显著增长，超过市场平均水平。目前交易价格低于公允价值估计，分析师的目标价格暗示在强劲利润扩张预期下，股票有升值潜力。</p>
<ul>
<li>点击这里通过我们的详细分析未来增长报告发现 Fiverr International 的细微差别。</li>
<li>根据我们的估值报告，Fiverr International 的股价可能偏低。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/af071c9b-3356-4e3c-b19f-688a0befb89f/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/af071c9b-3356-4e3c-b19f-688a0befb89f/chart/ownership-breakdown"/></p>
<p>截至 2026 年 1 月的 FVRR 持股分布</p>
<h2>接下来该怎么办？</h2>
<ul>
<li>解锁更多宝藏！我们的高内部持股快速成长的美国公司筛选器为您挖掘了 208 家公司供您探索。点击这里揭示我们精心策划的 211 家高内部持股快速成长的美国公司列表。</li>
<li>准备好不同的投资方式了吗？通过提供可靠收入流的稳健分红股来多样化您的投资组合，以应对潜在的市场动荡。</li>
</ul>
<p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
<p>国防和灾难的移动基础设施</p>
<p>下一波机器人技术不是类人型的。它是完全自主的塔，在 30 分钟内提供 5G、ISR 和雷达服务，适用于任何地方。</p>
<p>在下一轮合同之前获取投资者简报</p>
<p>由 CiTech 赞助</p>

超微电脑

FVRR

Abeona治疗

<p>随着 2025 年接近尾声，美国股市显示出显著的增长，激发了对高内部持股的成长型公司的兴趣。值得注意的公司包括超微电脑（Super Micro Computer，SMCI）、StubHub Holdings（STUB）和 SES AI（SES），它们都展现了强劲的盈利增长。亮点包括 Abeona Therapeutics，该公司正在开发基因疗法，预计收入增长为 42.5%；以及 Streamex Corp.，专注于将现实世界资产进行代币化，预计收入增长超过 100%。Fiverr International 也显示出潜力，预计盈利增长为 47.5%</p>

<p>As 2025 comes to a close, the U.S. stock market has experienced a robust year with significant gains across major indices despite ending on a slightly downbeat note. In this environment, identifying growth companies with high insider ownership can be particularly appealing as insider confidence often signals potential for long-term success and alignment of interests with shareholders.</p>
<div class="lb-trans"><p>随着 2025 年接近尾声，美国股市经历了一个强劲的年度，主要指数均实现了显著的涨幅，尽管最后略显疲软。在这种环境下，识别高内部持股的成长型公司尤为吸引人，因为内部人士的信心通常预示着长期成功的潜力以及与股东利益的一致性。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In The United States</h3>
<div class="lb-trans"><h3>美国高内部持股的十大成长型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Super Micro Computer (SMCI)</td>
<td>13.9%</td>
<td>50.7%</td>
</tr>
<tr>
<td>StubHub Holdings (STUB)</td>
<td>14.1%</td>
<td>59%</td>
</tr>
<tr>
<td>SES AI (SES)</td>
<td>12%</td>
<td>68.9%</td>
</tr>
<tr>
<td>Prairie Operating (PROP)</td>
<td>31.8%</td>
<td>100%</td>
</tr>
<tr>
<td>Niu Technologies (NIU)</td>
<td>37.2%</td>
<td>93.7%</td>
</tr>
<tr>
<td>Credo Technology Group Holding (CRDO)</td>
<td>10.1%</td>
<td>30.7%</td>
</tr>
<tr>
<td>Corcept Therapeutics (CORT)</td>
<td>11.5%</td>
<td>43.3%</td>
</tr>
<tr>
<td>Bitdeer Technologies Group (BTDR)</td>
<td>33.4%</td>
<td>135.5%</td>
</tr>
<tr>
<td>Atour Lifestyle Holdings (ATAT)</td>
<td>18%</td>
<td>24.4%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.5%</td>
<td>29.0%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>超微电脑 (SMCI)</td>
<td>13.9%</td>
<td>50.7%</td>
</tr>
<tr>
<td>StubHub Holdings (STUB)</td>
<td>14.1%</td>
<td>59%</td>
</tr>
<tr>
<td>SES AI (SES)</td>
<td>12%</td>
<td>68.9%</td>
</tr>
<tr>
<td>Prairie Operating (PROP)</td>
<td>31.8%</td>
<td>100%</td>
</tr>
<tr>
<td>Niu Technologies (NIU)</td>
<td>37.2%</td>
<td>93.7%</td>
</tr>
<tr>
<td>Credo Technology Group Holding (CRDO)</td>
<td>10.1%</td>
<td>30.7%</td>
</tr>
<tr>
<td>Corcept Therapeutics (CORT)</td>
<td>11.5%</td>
<td>43.3%</td>
</tr>
<tr>
<td>Bitdeer Technologies Group (BTDR)</td>
<td>33.4%</td>
<td>135.5%</td>
</tr>
<tr>
<td>Atour Lifestyle Holdings (ATAT)</td>
<td>18%</td>
<td>24.4%</td>
</tr>
<tr>
<td>Astera Labs (ALAB)</td>
<td>10.5%</td>
<td>29.0%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 211 stocks from our Fast Growing US Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>点击这里查看我们高内部持股快速成长的美国公司筛选器中的 211 只股票的完整列表。</p>
</div><p>Below we spotlight a couple of our favorites from our exclusive screener.</p>
<div class="lb-trans"><p>下面我们重点介绍几家我们独家的筛选器中的最爱。</p>
</div><h2>Abeona Therapeutics (ABEO)</h2>
<div class="lb-trans"><h2>Abeona Therapeutics (ABEO)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing gene and cell therapies for life-threatening diseases, with a market cap of $280.71 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Abeona Therapeutics Inc.是一家临床阶段的生物制药公司，专注于开发针对危及生命疾病的基因和细胞疗法，市值为 2.8071 亿美元。</p>
</div><p><strong>Operations:</strong> Abeona Therapeutics Inc. currently does not report any revenue segments as it is focused on developing gene and cell therapies for life-threatening diseases.</p>
<div class="lb-trans"><p><strong>运营：</strong> Abeona Therapeutics Inc.目前没有报告任何收入细分，因为它专注于开发针对危及生命疾病的基因和细胞疗法。</p>
</div><p><strong>Insider Ownership:</strong> 10.3%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 10.3%</p>
</div><p>Abeona Therapeutics, a company with substantial insider ownership, is experiencing significant growth potential. Recently becoming profitable, it trades at a value below its estimated fair value and peers. Despite some shareholder dilution over the past year, Abeona's revenue is forecast to grow at 42.5% annually, outpacing the US market average. The company's recent product developments include FDA-approved ZEVASKYN gene therapy for treating rare skin disorders and strategic leadership appointments to enhance business operations and development strategies.</p>
<div class="lb-trans"><p>Abeona Therapeutics 是一家拥有大量内部持股的公司，正经历显著的增长潜力。最近实现盈利，交易价格低于其估计的公允价值和同行。尽管过去一年股东稀释了一些股份，但 Abeona 的收入预计将以每年 42.5% 的速度增长，超过美国市场的平均水平。该公司最近的产品开发包括 FDA 批准的 ZEVASKYN 基因疗法，用于治疗罕见皮肤疾病，以及战略性领导任命，以增强业务运营和发展战略。</p>
</div><ul>
<li>Delve into the full analysis future growth report here for a deeper understanding of Abeona Therapeutics.</li>
<li>Our valuation report unveils the possibility Abeona Therapeutics' shares may be trading at a discount.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里深入了解 Abeona Therapeutics 的完整分析和未来增长报告。</li>
<li>我们的估值报告揭示了 Abeona Therapeutics 的股票可能在折扣交易。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/39d195f1-9226-485e-ab87-b8869e7f9946/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/39d195f1-9226-485e-ab87-b8869e7f9946/chart/earnings-and-revenue-growth"/></p>
<p>ABEO Earnings and Revenue Growth as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 ABEO 收益和收入增长</p>
</div><h2>Streamex (STEX)</h2>
<div class="lb-trans"><h2>Streamex (STEX)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Streamex Corp. is a real world asset tokenization company that provides institutional-grade infrastructure, with a market cap of $461.52 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Streamex Corp.是一家现实世界资产代币化公司，提供机构级基础设施，市值为 4.6152 亿美元。</p>
</div><p><strong>Operations:</strong> Streamex Corp.'s revenue segments are not specified in the provided text.</p>
<div class="lb-trans"><p><strong>运营：</strong> 提供的文本中未指定 Streamex Corp.的收入细分。</p>
</div><p><strong>Insider Ownership:</strong> 16.1%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 16.1%</p>
</div><p>Streamex, with significant insider ownership, is positioned for growth through innovative initiatives like Project Open and strategic partnerships. The company's focus on tokenizing real-world assets, such as its gold-backed GLDY token, aligns with regulatory advancements to enhance market transparency and efficiency. Despite recent financial losses of US$15.58 million in Q3 2025 and shareholder dilution, Streamex's revenue is projected to grow rapidly at over 100% annually, outpacing the US market average.</p>
<div class="lb-trans"><p>Streamex 拥有显著的内部持股，通过创新举措如开放项目和战略合作伙伴关系，正处于增长的有利位置。该公司专注于代币化现实世界资产，例如其黄金支持的 GLDY 代币，与监管进展相一致，以增强市场透明度和效率。尽管在 2025 年第三季度遭遇了 1558 万美元的财务损失和股东稀释，Streamex 的收入预计将以每年超过 100% 的速度快速增长，超过美国市场的平均水平。</p>
</div><ul>
<li>Click here and access our complete growth analysis report to understand the dynamics of Streamex.</li>
<li>According our valuation report, there's an indication that Streamex's share price might be on the expensive side.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们的完整增长分析报告，以了解 Streamex 的动态。</li>
<li>根据我们的估值报告，Streamex 的股价可能偏高。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d17f23ca-2239-4854-a67b-12352d918c07/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/d17f23ca-2239-4854-a67b-12352d918c07/chart/earnings-and-revenue-growth"/></p>
<p>STEX Earnings and Revenue Growth as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 STEX 收益和收入增长</p>
</div><h2>Fiverr International (FVRR)</h2>
<div class="lb-trans"><h2>Fiverr International (FVRR)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Fiverr International Ltd. operates a global online marketplace and has a market cap of approximately $727.95 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Fiverr International Ltd.运营一个全球在线市场，市值约为 7.2795 亿美元。</p>
</div><p><strong>Operations:</strong> The company generates $427.40 million in revenue from its Internet Software &amp; Services segment.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司从其互联网软件和服务部门产生 4.2740 亿美元的收入。</p>
</div><p><strong>Insider Ownership:</strong> 11.6%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 11.6%</p>
</div><p>Fiverr International, with substantial insider ownership, has demonstrated strong earnings growth, reporting a net income of US$5.54 million in Q3 2025 compared to US$1.35 million the previous year. Despite revenue growth forecasts lagging behind the broader market at 6.3% annually, its earnings are projected to grow significantly at 47.5% per year, surpassing market averages. Currently trading below fair value estimates and analyst price targets suggest potential for stock appreciation amidst robust profit expansion expectations.</p>
<div class="lb-trans"><p>Fiverr International 拥有大量内部持股，展现出强劲的收益增长，在 2025 年第三季度报告的净收入为 554 万美元，而去年为 135 万美元。尽管收入增长预测落后于更广泛的市场，年增长率为 6.3%，但其收益预计将以每年 47.5% 的速度显著增长，超过市场平均水平。目前交易价格低于公允价值估计，分析师的目标价格暗示在强劲利润扩张预期下，股票有升值潜力。</p>
</div><ul>
<li>Click here to discover the nuances of Fiverr International with our detailed analytical future growth report.</li>
<li>According our valuation report, there's an indication that Fiverr International's share price might be on the cheaper side.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里通过我们的详细分析未来增长报告发现 Fiverr International 的细微差别。</li>
<li>根据我们的估值报告，Fiverr International 的股价可能偏低。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/af071c9b-3356-4e3c-b19f-688a0befb89f/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/af071c9b-3356-4e3c-b19f-688a0befb89f/chart/ownership-breakdown"/></p>
<p>FVRR Ownership Breakdown as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 FVRR 持股分布</p>
</div><h2>Where To Now?</h2>
<div class="lb-trans"><h2>接下来该怎么办？</h2>
</div><ul>
<li>Unlock more gems! Our Fast Growing US Companies With High Insider Ownership screener has unearthed 208 more companies for you to explore.Click here to unveil our expertly curated list of 211 Fast Growing US Companies With High Insider Ownership.</li>
<li>Ready For A Different Approach? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁更多宝藏！我们的高内部持股快速成长的美国公司筛选器为您挖掘了 208 家公司供您探索。点击这里揭示我们精心策划的 211 家高内部持股快速成长的美国公司列表。</li>
<li>准备好不同的投资方式了吗？通过提供可靠收入流的稳健分红股来多样化您的投资组合，以应对潜在的市场动荡。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>国防和灾难的移动基础设施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波机器人技术不是类人型的。它是完全自主的塔，在 30 分钟内提供 5G、ISR 和雷达服务，适用于任何地方。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一轮合同之前获取投资者简报</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>由 CiTech 赞助</p>
</div>

3 Insider-Owned Growth Stocks For Your Watchlist

- 2025 年美股表现强劲，主要指数均有显著增长。  
- 高内部持股的成长公司吸引关注，反映内部联系与股东利益一致。  
- 列举多家公司，含 Abeona Therapeutics 及 Streamex，其收入预计将显著增长。

3 只由内部人士持有的成长型股票值得您关注